We have located links that may give you full text access.
Development of decellularized meniscus extracellular matrix and gelatin/chitosan scaffolds for meniscus tissue engineering.
Bio-medical Materials and Engineering 2019 Februrary 7
BACKGROUND: The meniscus tissue engineering has provided a great potential treatment for meniscal injuries. However, few scaffolds in meniscus tissue engineering have matched the mechanical properties of native meniscus.
OBJECTIVE: In this study,we developed a composite scaffold using decellularized meniscus extracellular matrix (DMECM) and gelatin/chitosan (G/C), to explore apreferable ratio to enhance the elastic modulus and cytotoxicity properties of scaffolds.
METHODS: Moreover, the microstructure, porosity, cytotoxicity, and strength of the composite scaffolds were also evaluated. The micro-architectures of the samples were evaluated using scanning electron microscope (SEM). Fourier Transform Infrared analysis (FTIR) (Brulcer Tensor 27, Ettlingen, Germany) was used to confirm the chemical structure with different type composite scaffolds. The compressive elastic modulus of all the scaffolds were measuredas by Universal tensile testing machine, DNS300 (Changchun testing machine research institute, China). Calcein-AM (green fluorescence) and Propidium Iodide (FUBAIKE, China) (red fluorescence) were used to stain live cells and dead cells respectively. Morphology and spatial distribution of cells within scaffolds were observed by confocal laser scanning microscopy FV 1000 (Nikon, Japan).
RESULTS: SEM showed that the composite scaffolds had suitable porous structure. CCK-8 and live/dead staining demonstrated that the composite scaffolds had no cytotoxicity and could promotebone marrow mesenchymal stem cells (BMSCs) proliferation. The FTIR results demonstrated the successful mixing of these two elements, and the addition of DMECM improved the elastic modulus and cytotoxicity of G/C composite scaffolds.
CONCLUSIONS: In summary, this study developed a composite scaffold using DMECM and G/C, and demonstrated it may be suitable for meniscal tissue engineering application.
OBJECTIVE: In this study,we developed a composite scaffold using decellularized meniscus extracellular matrix (DMECM) and gelatin/chitosan (G/C), to explore apreferable ratio to enhance the elastic modulus and cytotoxicity properties of scaffolds.
METHODS: Moreover, the microstructure, porosity, cytotoxicity, and strength of the composite scaffolds were also evaluated. The micro-architectures of the samples were evaluated using scanning electron microscope (SEM). Fourier Transform Infrared analysis (FTIR) (Brulcer Tensor 27, Ettlingen, Germany) was used to confirm the chemical structure with different type composite scaffolds. The compressive elastic modulus of all the scaffolds were measuredas by Universal tensile testing machine, DNS300 (Changchun testing machine research institute, China). Calcein-AM (green fluorescence) and Propidium Iodide (FUBAIKE, China) (red fluorescence) were used to stain live cells and dead cells respectively. Morphology and spatial distribution of cells within scaffolds were observed by confocal laser scanning microscopy FV 1000 (Nikon, Japan).
RESULTS: SEM showed that the composite scaffolds had suitable porous structure. CCK-8 and live/dead staining demonstrated that the composite scaffolds had no cytotoxicity and could promotebone marrow mesenchymal stem cells (BMSCs) proliferation. The FTIR results demonstrated the successful mixing of these two elements, and the addition of DMECM improved the elastic modulus and cytotoxicity of G/C composite scaffolds.
CONCLUSIONS: In summary, this study developed a composite scaffold using DMECM and G/C, and demonstrated it may be suitable for meniscal tissue engineering application.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app